Antiretroviral therapy coverage (% of people living with HIV) in Chile
Chile: Antiretroviral therapy coverage (% of people living with HIV) was 71.0% in 2024. ▲ Rising
Antiretroviral therapy coverage in Chile, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
Chile recorded 71.0% for antiretroviral therapy coverage in 2024.
The figure is down 5.3% on the previous year and up 29.1% over ten years.
Over the whole period, antiretroviral therapy coverage in Chile peaked at 76.0% in 2019 and was at its lowest, 11.0%, in 2000.
That places Chile 74th out of 143 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 25 years of available data.
Antiretroviral therapy coverage (% of people living with HIV) in Chile, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 11.0% | — |
| 2001 | 14.0% | +27.3% |
| 2002 | 19.0% | +35.7% |
| 2003 | 24.0% | +26.3% |
| 2004 | 25.0% | +4.2% |
| 2005 | 34.0% | +36.0% |
| 2006 | 33.0% | -2.9% |
| 2007 | 35.0% | +6.1% |
| 2008 | 35.0% | +0.0% |
| 2009 | 38.0% | +8.6% |
| 2010 | 40.0% | +5.3% |
| 2011 | 41.0% | +2.5% |
| 2012 | 47.0% | +14.6% |
| 2013 | 51.0% | +8.5% |
| 2014 | 55.0% | +7.8% |
| 2015 | 57.0% | +3.6% |
| 2016 | 62.0% | +8.8% |
| 2017 | 69.0% | +11.3% |
| 2018 | 74.0% | +7.2% |
| 2019 | 76.0% | +2.7% |
| 2020 | 76.0% | +0.0% |
| 2021 | 75.0% | -1.3% |
| 2022 | 76.0% | +1.3% |
| 2023 | 75.0% | -1.3% |
| 2024 | 71.0% | -5.3% |
Chile compared with similar countries
- Chile's 71.0% is below the median for high income countries, which is 83.0%, 86% of the median. (40 countries reporting)
- Chile's 71.0% is above the median for Latin America & Caribbean, which is 67.5%, 1.1× the median. (24 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 26.8% | 11.0% | 38.0% | 10 |
| 2010s | 57.2% | 40.0% | 76.0% | 10 |
| 2020s | 74.6% | 71.0% | 76.0% | 5 |
Countries ranked near Chile
More health data for Chile
- Un projection of annual infant deaths, annual growth rate -1.71 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4062 % change on previous year (2090)
- Un projection of annual infant deaths 115 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.22 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0224 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.16 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0233 units per person (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Chile?
- Antiretroviral therapy coverage in Chile was 71.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Chile?
- The highest recorded value was 76.0% in 2019.
- What is the lowest antiretroviral therapy coverage recorded in Chile?
- The lowest recorded value was 11.0% in 2000.
- How does Chile rank for antiretroviral therapy coverage?
- Chile ranks 74th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Chile?
- Over the last ten years it is up 29.1%. The long-run trend across the full record is rising.
- Where does this Chile data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.